BMS-986012, an Anti-Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study
BMS-986012，一种抗岩藻糖基-GM1单克隆抗体，作为单药疗法或与纳武利尤单抗联合用于复发/难治性小细胞肺癌：一项首次人体1/2期研究的结果
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2022.100400
Chu, Quincy; Leighl, Natasha B; Surmont, Veerle; van Herpen, Carla; Sibille, Anne; Markman, Ben; Clarke, Stephen; Juergens, Rosalyn A; Rivera, Mirelis Acosta; Andelkovic, Vladimir; Rudin, Charles M; Snow, Stephanie; Kim, Dong-Wan; Sanatani, Michael; Lin, Hongxia; Sanghavi, Kinjal; Tannenbaum-Dvir, Sarah; Basciano, Paul; Lathers, Deanne; Urbanska, Katarzyna; Kollia, Georgia; He, Chunsheng; DiPiero, Andrew; Liu, Yu; Ready, Neal
单克隆抗体
肺癌
肿瘤
肿瘤免疫
多发性硬化症
Human
细胞生物学
